Stephen A. Trowbridge serves as the Executive Vice President and Chief Financial Officer (EVP, CFO) at AngioDynamics Inc., a leading provider of medical devices used in minimally invasive procedures. In his role, Trowbridge is responsible for overseeing the company's financial operations, including financial planning and analysis, accounting, investor relations, and treasury management. His strategic vision and financial acumen have been instrumental in guiding AngioDynamics through periods of growth and innovation in the competitive medical device industry. Before joining AngioDynamics, Trowbridge held several senior financial positions at notable companies within the healthcare and life sciences sectors. He previously served as the CFO at Lantheus Medical Imaging, where he played a key role in the company's financial restructuring and subsequent growth. Earlier in his career, Trowbridge worked at PerkinElmer, Inc., in various finance roles, gaining extensive experience in financial management and corporate strategy. His background in these roles has equipped him with the expertise needed to drive AngioDynamics' financial performance and support the company's mission to improve patient outcomes through innovative medical technologies. Trowbridge's achievements at AngioDynamics include leading the company through successful acquisitions and integrations, which have expanded the company's product portfolio and market reach. Under his leadership, AngioDynamics has maintained a strong financial position, enabling continued investment in research and development. Trowbridge's commitment to excellence and his ability to navigate complex financial landscapes have made him a valuable asset to AngioDynamics and a respected leader in the medical device industry.